References
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. [cited 2021 Feb 4]. Epub ahead of print. doi:https://doi.org/10.3322/caac.21660Cited in: PMID: 33538338.
- Metwally IH, Shetiwy M, Elalfy AF, Abouzid A, Saleh SS, Hamdy M. Epidemiology and survival of colon cancer among Egyptians: a retrospective study. J Coloproctol. 2018;38(1):24–29. doi:https://doi.org/10.1016/j.jcol.2017.09.418
- Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, Sinicrope FA, Rosty C, Buchanan DD, Potter JD, et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology. 2015;148(1):77–87.e2. doi:https://doi.org/10.1053/j.gastro.2014.09.038
- Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546–1558. doi:https://doi.org/10.1126/science.1235122
- Zhang Q, Yu N, Lee C. Mysteries of TGF-β paradox in benign and malignant cells. Front Oncol. 2014;4:94. doi:https://doi.org/10.3389/fonc.2014.00094
- Witkowska M, Smolewski P. [SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases]. Postepy Hig Med Dosw. 2014;68:301–309. doi:https://doi.org/10.5604/17322693.1094726
- Principe DR, DeCant B, Staudacher J, Vitello D, Mangan RJ, Wayne EA, Mascariñas E, Diaz AM, Bauer J, McKinney RD, et al. Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation. Oncotarget. 2017;8(3):3826–3839. doi:https://doi.org/10.18632/oncotarget.9830
- Loomans HA, Andl CD. Intertwining of activin A and TGFβ signaling: dual roles in cancer progression and cancer cell invasion. Cancers. 2014;7(1):70–91. doi:https://doi.org/10.3390/cancers7010070
- Refaat B, El-Shemi AG, Mohamed AM, Kensara OA, Ahmad J, Idris S. Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer. BMC Cancer. 2016;16(1):879. doi:https://doi.org/10.1186/s12885-016-2914-9
- Marino FE, Risbridger G, Gold E. The therapeutic potential of blocking the activin signalling pathway. Cytokine Growth Factor Rev. 2013;24(5):477–484. doi:https://doi.org/10.1016/j.cytogfr.2013.04.006
- Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119(6):1438–1449. doi:https://doi.org/10.1172/JCI38019
- Shemesh N, Arber N. Curcumin alone and in combination for prevention of colorectal cancer. Curr Colorectal Cancer Rep. 2014;10(1):62–67. doi:https://doi.org/10.1007/s11888-013-0207-0
- Ashmawy AM, Azab SS, Eldahshan OA. Effects of Chorisia crispiflora ethyl acetate extract on P21 and NF-κB in breast cancer cells. J Am Sci. 2012;8(8):965–972.
- Meiyanto E, Hermawan A, Anindyajati A. Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev. 2012;13(2):427–436. doi:https://doi.org/10.7314/apjcp.2012.13.2.427
- Majumdar S, Srirangam R. Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid. Pharm Res. 2009;26(5):1217–1225. doi:https://doi.org/10.1007/s11095-008-9729-6
- Tanaka T, Tanaka T, Tanaka M, Kuno T. Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin. J Biomed Biotechnol. 2012;2012:516981. doi:https://doi.org/10.1155/2012/516981
- Yu H-B, Li L, Ren Z-X, Shen J-L. Inhibition of hesperidin on epithelial to mesenchymal transition of non-small cell lung cancer cells induced by TGF-beta 1. Indian J Pharm Educ Res. 2016;50(4):583–590. doi:https://doi.org/10.5530/ijper.50.4.10
- Cincin ZB, Kiran B, Baran Y, Cakmakoglu B. Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells. Biomed Pharmacother. 2018;103:336–345. doi:https://doi.org/10.1016/j.biopha.2018.04.020
- Bordini HP, Kremer JL, Fagundes TR, Melo GP, Conchon-Costa I, da Silva SS, Cecchini AL, Panis C, Luiz RC. Protective effect of metformin in an aberrant crypt foci model induced by 1,2-dimethylhydrazine: modulation of oxidative stress and inflammatory process. Mol Carcinog. 2017;56(3):913–922. doi:https://doi.org/10.1002/mc.22545
- Saiprasad G, Chitra P, Manikandan R, Sudhandiran G. Hesperidin alleviates oxidative stress and downregulates the expressions of proliferative and inflammatory markers in azoxymethane-induced experimental colon carcinogenesis in mice. Inflamm Res. 2013;62(4):425–440. doi:https://doi.org/10.1007/s00011-013-0595-2
- Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995;93(1):55–71. doi:https://doi.org/10.1016/0304-3835(95)03788-X
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi:https://doi.org/10.1006/meth.2001.1262
- Paya D, Maupoil V, Schott C, Rochette L, Stoclet JC. Temporal relationships between levels of circulating NO derivatives, vascular NO production and hyporeactivity to noradrenaline induced by endotoxin in rats. Cardiovasc Res. 1995;30(6):952–959. doi:https://doi.org/10.1016/0008-6363(95)00155-7
- Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77. doi:https://doi.org/10.1016/0003-9861(59)90090-6
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–275. doi:https://doi.org/10.1016/S0021-9258(19)52451-6
- Bancroft JD, Gamble M. Theory and practice of histological techniques. Elsevier Health Sciences; 2008.
- Mazières J, Brugger W, Cappuzzo F, Middel P, Frosch A, Bara I, Klingelschmitt G, Klughammer B. Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study. Lung Cancer. 2013;82(2):231–237. doi:https://doi.org/10.1016/j.lungcan.2013.07.016
- Rouhollahi E, Moghadamtousi SZ, Al-Henhena N, Kunasegaran T, Hasanpourghadi M, Looi CY, Abd Malek SN, Awang K, Abdulla MA, Mohamed Z, et al. The chemopreventive potential of Curcuma purpurascens rhizome in reducing azoxymethane-induced aberrant crypt foci in rats. Drug Des Devel Ther. 2015;9:3911–3922. doi:https://doi.org/10.2147/DDDT.S84560
- Arivalagan S, Thomas NS, Chandrasekaran B, Mani V, Siddique AI, Kuppsamy T, Namasivayam N. Combined therapeutic efficacy of carvacrol and X-radiation against 1,2-dimethyl hydrazine-induced experimental rat colon carcinogenesis. Mol Cell Biochem. 2015;410(1–2):37–54. doi:https://doi.org/10.1007/s11010-015-2536-6
- Muthu R, Selvaraj N, Vaiyapuri M. Anti-inflammatory and proapoptotic effects of umbelliferone in colon carcinogenesis. Hum Exp Toxicol. 2016;35(10):1041–1054. doi:https://doi.org/10.1177/0960327115618245
- Aranganathan S, Nalini N. Efficacy of the potential chemopreventive agent, hesperetin (citrus flavanone), on 1,2-dimethylhydrazine induced colon carcinogenesis. Food Chem Toxicol. 2009;47(10):2594–2600. doi:https://doi.org/10.1016/j.fct.2009.07.019
- Aranganathan S, Nalini N. Antiproliferative efficacy of hesperetin (citrus flavonoid) in 1,2‐dimethylhydrazine‐induced colon cancer. Phytother Res. 2013;27(7):999–1005. doi:https://doi.org/10.1002/ptr.4826
- Sharma SH, Chellappan DR, Chinnaswamy P, Nagarajan S. Protective effect of p-coumaric acid against 1,2 dimethylhydrazine induced colonic preneoplastic lesions in experimental rats. Biomed Pharmacother. 2017;94:577–588. doi:https://doi.org/10.1016/j.biopha.2017.07.146
- Rehman MU, Rahman Mir MU, Farooq A, Rashid SM, Ahmad B, Bilal Ahmad S, Ali R, Hussain I, Masoodi M, Muzamil S, et al. Naringenin (4,5,7-trihydroxyflavanone) suppresses the development of precancerous lesions via controlling hyperproliferation and inflammation in the colon of Wistar rats. Environ Toxicol. 2018;33(4):422–435. doi:https://doi.org/10.1002/tox.22528
- Muthu R, Thangavel P, Selvaraj N, Ramalingam R, Vaiyapuri M. Synergistic and individual effects of umbelliferone with 5-fluorouracil on the status of lipid peroxidation and antioxidant defense against 1,2-dimethylhydrazine induced rat colon carcinogenesis. Biomed Prev Nutr. 2013;3(1):74–82. doi:https://doi.org/10.1016/j.bionut.2012.10.011
- Hirose Y. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis. 2003;24(1):107–111. doi:https://doi.org/10.1093/carcin/24.1.107
- Kensara OA, El-Shemi AG, Mohamed AM, Refaat B, Idris S, Ahmad J. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats. Drug Des Devel Ther. 2016;10:2239–2253. doi:https://doi.org/10.2147/DDDT.S109721
- Fleming NI, Jorissen RN, Mouradov D, Christie M, Sakthianandeswaren A, Palmieri M, Day F, Li S, Tsui C, Lipton L, et al. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res. 2013;73(2):725–735. doi:https://doi.org/10.1158/0008-5472.CAN-12-2706
- Papageorgis P, Cheng K, Ozturk S, Gong Y, Lambert AW, Abdolmaleky HM, Zhou J-R, Thiagalingam S. Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Res. 2011;71(3):998–1008. doi:https://doi.org/10.1158/0008-5472.CAN-09-3269
- Boulay JL, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C. SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer. 2002;87(6):630–634. doi:https://doi.org/10.1038/sj.bjc.6600511
- Li W, Kandhare AD, Mukherjee AA, Bodhankar SL. Hesperidin, a plant flavonoid accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats: role of TGF-ß/Smads and Ang-1/Tie-2 signaling pathways. EXCLI J. 2018;17:399–419.
- Mahmoud AM, Mohammed HM, Khadrawy SM, Galaly SR. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation. Chem Biol Interact. 2017;277:146–158. doi:https://doi.org/10.1016/j.cbi.2017.09.015
- Yang Y, Wolfram J, Shen H, Fang X, Ferrari M. Hesperetin: an inhibitor of the transforming growth factor-β (TGF-β) signaling pathway. Eur J Med Chem. 2012;58:390–395. doi:https://doi.org/10.1016/j.ejmech.2012.10.028
- Zhao M, Mishra L, Deng CX. The role of TGF-β/SMAD4 signaling in cancer. Int J Biol Sci. 2018;14(2):111–123. doi:https://doi.org/10.7150/ijbs.23230
- Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ. TGF-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst. 2014;106(2):djt369. doi:https://doi.org/10.1093/jnci/djt369
- Slattery ML, Lundgreen A, Herrick JS, Wolff RK, Caan BJ. Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer. 2011;117(18):4175–4183. doi:https://doi.org/10.1002/cncr.26018
- Okano MIHO, Yamamoto H, Ohkuma H, Kano Y, Kim H, Nishikawa S, Konno M, Kawamoto K, Haraguchi N, Takemasa I, et al. Significance of INHBA expression in human colorectal cancer. Oncol Rep. 2013;30(6):2903–2908. doi:https://doi.org/10.3892/or.2013.2761
- Wu S, Qi Y, Niu LM, Xie DX, Cui XL, Liu ZH. Activin A as a novel biomarker for colorectal adenocarcinoma in humans. Eur Rev Med Pharmacol Sci. 2015;19(22):4371–4378.
- Xu R-H, Sampsell-Barron TL, Gu F, Root S, Peck RM, Pan G, Yu J, Antosiewicz-Bourget J, Tian S, Stewart R, et al. NANOG is a direct target of TGFβ/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell. 2008;3(2):196–206. doi:https://doi.org/10.1016/j.stem.2008.07.001
- Xia Y, Schneyer AL. The biology of activin: recent advances in structure, regulation and function. J Endocrinol. 2009;202(1):1–12. doi:https://doi.org/10.1677/JOE-08-0549
- Zhang Y, Bao Y-L, Yang M-T, Wu Y, Yu C-L, Huang Y-X, Sun Y, Zheng L-H, Li Y-X. Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells. Int J Biochem Cell Biol. 2010;42(12):1964–1972. doi:https://doi.org/10.1016/j.biocel.2010.08.007
- Bauer J, Sporn JC, Cabral J, Gomez J, Jung B. Effects of activin and TGFβ on p21 in colon cancer. PLoS One. 2012;7(6):e39381. doi:https://doi.org/10.1371/journal.pone.0039381
- Ottley E, Gold E. Insensitivity to the growth inhibitory effects of activin A: an acquired capability in prostate cancer progression. Cytokine Growth Factor Rev. 2012; 23(3):119–125. doi:https://doi.org/10.1016/j.cytogfr.2012.04.004
- Grossi V, Peserico A, Tezil T, Simone C. p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol. 2014;20(29):9744–9758. doi:https://doi.org/10.3748/wjg.v20.i29.9744
- Jung B, Gomez J, Chau E, Cabral J, Lee JK, Anselm A, Slowik P, Ream-Robinson D, Messer K, Sporn J, et al. Activin signaling in microsatellite stable colon cancers is disrupted by a combination of genetic and epigenetic mechanisms. PLoS One. 2009;4(12):e8308. doi:https://doi.org/10.1371/journal.pone.0008308
- Jung BH, Beck SE, Cabral J, Chau E, Cabrera BL, Fiorino A, Smith EJ, Bocanegra M, Carethers JM. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin. Gastroenterology. 2007;132(2):633–644. doi:https://doi.org/10.1053/j.gastro.2006.11.018
- Le Bras GF, Loomans HA, Taylor CJ, Revetta FL, Andl CD. Activin A balance regulates epithelial invasiveness and tumorigenesis. Lab Invest. 2014;94(10):1134–1146. doi:https://doi.org/10.1038/labinvest.2014.97
- Sonoyama K, Pholnukulkit P, Toyoda M, Rutatip S, Kasai T. Upregulation of activin A gene by butyrate in human colon cancer cell lines. Am J Physiol Gastrointest Liver Physiol. 2003;284(6):G989–G995. doi:https://doi.org/10.1152/ajpgi.00384.2002
- Wilson C, Ottewell P, Coleman RE, Holen I. The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway. BMC Cancer. 2015;15(1):55. doi:https://doi.org/10.1186/s12885-015-1066-7
- Refaat B, El-Shemi AG, Ashshi AM. The effects of pegylated interferon-alpha and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary report. BMC Res Notes. 2015;8(1):265. doi:https://doi.org/10.1186/s13104-015-1253-2
- Yang C, Liu J, Liu K, Du B, Shi K, Ding M, Li B, Yang P. Ghrelin suppresses cardiac fibrosis of post-myocardial infarction heart failure rats by adjusting the activin A-follistatin imbalance. Peptides. 2018;99:27–35. doi:https://doi.org/10.1016/j.peptides.2017.10.018
- Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266(1–2):37–56. doi:https://doi.org/10.1023/B:MCBI.0000049134.69131.89
- Khan R, Khan AQ, Qamar W, Lateef A, Tahir M, Rehman MU, Ali F, Sultana S. Chrysin protects against cisplatin-induced colon. Toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53. Toxicol Appl Pharmacol. 2012;258(3):315–329. doi:https://doi.org/10.1016/j.taap.2011.11.013
- Ashokkumar P, Sudhandiran G. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Pharmacother. 2008;62(9):590–597. doi:https://doi.org/10.1016/j.biopha.2008.06.031
- Ghadi FE, Ghara AR, Bhattacharyya S, Dhawan DK. Selenium as a chemopreventive agent in experimentally induced colon carcinogenesis. World J Gastrointest Oncol. 2009;1(1):74–81. doi:https://doi.org/10.4251/wjgo.v1.i1.74
- Venkatachalam K, Gunasekaran S, Jesudoss VAS, Namasivayam N. The effect of rosmarinic acid on 1,2-dimethylhydrazine induced colon carcinogenesis. Exp Toxicol Pathol. 2013;65(4):409–418. doi:https://doi.org/10.1016/j.etp.2011.12.005
- Arigesavan K, Sudhandiran G. Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1,2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats. Biochem Biophys Res Commun. 2015;461(2):314–320. doi:https://doi.org/10.1016/j.bbrc.2015.04.030
- Surh Y-J, Chun K-S, Cha H-H, Han SS, Keum Y-S, Park K-K, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res. 2001;480–481:243–268. doi:https://doi.org/10.1016/S0027-5107(01)00183-X
- Abdel-Raheem IT, Abdel-Ghany AA. Hesperidin alleviates doxorubicin-induced cardiotoxicity in rats. J Egypt Natl Canc Inst. 2009;21(2):175–184.
- Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160(1):1–40. doi:https://doi.org/10.1016/j.cbi.2005.12.009
- Matés JM, Segura JA, Alonso FJ, Márquez J. Oxidative stress in apoptosis and cancer: an update. Arch Toxicol. 2012;86(11):1649–1665. doi:https://doi.org/10.1007/s00204-012-0906-3
- Masella R, Di Benedetto R, Varì R, Filesi C, Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem. 2005;16(10):577–586. doi:https://doi.org/10.1016/j.jnutbio.2005.05.013
- Balaji C, Muthukumaran J, Nalini N. Chemopreventive effect of sinapic acid on 1,2-dimethylhydrazine-induced experimental rat colon carcinogenesis. Hum Exp Toxicol. 2014;33(12):1253–1268. doi:https://doi.org/10.1177/0960327114522501
- Aranganathan S, Panneer Selvam J, Nalini N. Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs. 2009;27(3):203–213. doi:https://doi.org/10.1007/s10637-008-9158-8